Enveric Biosciences, Inc. (ENVB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 5M 10M 15M Q2 '14: 4M Q1 '15: 4.3M Q2 '15: 3.9M Q3 '15: 4.5M Q4 '15: 7.6M Q1 '16: 7M Q2 '16: 6.7M Q3 '16: 10.1M Q4 '16: 12.4M Q1 '17: 12.3M Q2 '17: 12.3M Q3 '17: 12.5M Q4 '17: 11.5M Q1 '18: 11.1M Q2 '18: 11.1M Q3 '18: 10.6M Q4 '18: 10.3M Q1 '19: 10.7M Q2 '19: 11M Q3 '19: 9.1M Q4 '19: 9.1M Q1 '20: 9.6M Q2 '20: 8.3M Q3 '20: 8.5M Q2 '15 Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19 Q3 '20

Gross Profit Quarterly

0 1.5M 3M 4.5M Q2 '10: 0 Q2 '11: 0 Q2 '14: 1.1M Q1 '15: 1.1M Q2 '15: 982.7K Q3 '15: 1.4M Q4 '15: 3.3M Q1 '16: 1.3M Q2 '16: 1.5M Q3 '16: 1.7M Q4 '16: 2.1M Q1 '17: 3.3M Q2 '17: 2.3M Q3 '17: 2.6M Q4 '17: 2M Q1 '18: 2.3M Q2 '18: 2.4M Q3 '18: 2.3M Q4 '18: 1.9M Q1 '19: 2.1M Q2 '19: 2.4M Q3 '19: 1.9M Q4 '19: 1.7M Q1 '20: 1.9M Q2 '20: 1.8M Q3 '20: 1.9M Q2 '11 Q3 '15 Q3 '16 Q3 '17 Q3 '18 Q3 '19 Q3 '20

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q1 '10: -14.4K Q2 '10: -4.5K Q3 '10: -5.6K Q4 '10: -11.4K Q1 '11: -11.1K Q2 '11: -3.6K Q3 '11: -3.7K Q4 '11: -13K Q1 '12: -4K Q2 '12: -4.1K Q3 '12: -4.6K Q4 '12: -10K Q1 '13: -4.7K Q2 '13: -3.9K Q3 '13: -4.6K Q4 '13: 40.4K Q1 '14: -7.6K Q2 '14: 575.2K Q3 '14: -3.1K Q4 '14: 55.2K Q1 '15: 1.1M Q2 '15: 180K Q3 '15: -315.8K Q1 '16: -981.3K Q2 '16: -936.6K Q3 '16: -1.3M Q4 '16: -2.2M Q1 '17: -630.5K Q2 '17: -3.5M Q3 '17: -3.9M Q4 '17: -3.2M Q1 '18: -1.4M Q2 '18: -1.1M Q3 '18: 6.1M Q4 '18: -10.8M Q1 '19: -1.3M Q2 '19: -1.5M Q3 '19: -1.6M Q4 '19: 2M Q1 '20: -836.7K Q2 '20: -767.5K Q3 '20: -489.8K Q4 '20: -3.5M Q1 '21: -6.8M Q2 '21: -3.4M Q3 '21: -3.5M Q4 '21: -51M Q1 '22: -4.8M Q2 '22: -4.7M Q3 '22: -5.7M Q4 '22: -12.3M Q1 '23: -4.9M Q2 '23: -5.8M Q3 '23: -3.4M Q4 '23: -2.4M Q1 '24: -2.5M Q2 '24: -1.9M Q3 '24: -2.1M Q4 '24: -3.2M Q1 '25: -2.2M Q2 '25: -2.5M Q3 '25: -1.9M Q4 '25: -2.2M Q1 '26: -1.6M Q2 '26: -3M Q2 '10 Q3 '12 Q4 '14 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '10: -20.3K Q2 '10: 0 Q3 '10: -5.6K Q4 '10: -13.5K Q1 '11: -11.1K Q2 '11: -3.6K Q3 '11: -3.7K Q4 '11: -15K Q1 '12: -4K Q2 '12: -4.1K Q3 '12: -4.9K Q4 '12: -11.6K Q1 '13: -4.7K Q2 '13: -3.9K Q3 '13: -4.6K Q4 '13: 13K Q1 '14: -7.9K Q2 '14: 408.4K Q3 '14: -3.2K Q4 '14: -10.7K Q1 '15: 1.1M Q2 '15: 111K Q3 '15: -159.5K Q1 '16: -1.2M Q2 '16: -1.2M Q3 '16: -1.8M Q4 '16: 1.4M Q1 '17: -722K Q2 '17: -3.3M Q3 '17: -4.1M Q4 '17: -1M Q1 '18: -1.6M Q2 '18: -1.3M Q3 '18: 5.7M Q4 '18: -19.8M Q1 '19: -1.9M Q2 '19: -1.3M Q3 '19: 41.3K Q4 '19: -2.6M Q1 '20: -1.1M Q2 '20: -818.4K Q3 '20: -565.3K Q4 '20: -4.4M Q1 '21: -3.3M Q2 '21: -908.3K Q3 '21: -2.7M Q4 '21: -42.1M Q1 '22: -4.5M Q2 '22: -2.8M Q3 '22: -2.5M Q4 '22: -8.7M Q1 '23: -4.7M Q2 '23: -6.4M Q3 '23: -2.8M Q4 '23: -3.4M Q1 '24: -2.5M Q2 '24: -1.9M Q3 '24: -2.1M Q4 '24: -3.2M Q1 '25: -2.2M Q2 '25: -2.5M Q3 '25: -1.9M Q4 '25: -2.2M Q1 '26: -1.6M Q2 '26: -3M Q2 '10 Q3 '12 Q4 '14 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 4M 8M 12M Q2 '10: 0 Q2 '11: 0 Q2 '14: 2.9M Q1 '15: 3.2M Q2 '15: 2.9M Q3 '15: 3M Q4 '15: 4.3M Q1 '16: 1.9M Q2 '16: 5.2M Q3 '16: 8.4M Q4 '16: 10.3M Q1 '17: 9M Q2 '17: 9.9M Q3 '17: 10M Q4 '17: 9.4M Q1 '18: 8.7M Q2 '18: 8.7M Q3 '18: 8.2M Q4 '18: 8.4M Q1 '19: 8.5M Q2 '19: 8.6M Q3 '19: 7.2M Q4 '19: 7.3M Q1 '20: 7.7M Q2 '20: 6.4M Q3 '20: 6.6M Q2 '11 Q3 '15 Q3 '16 Q3 '17 Q3 '18 Q3 '19 Q3 '20

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '10: -38.9K Q4 '10: -3K Q1 '11: -17K Q2 '11: -4.9K Q3 '11: -3.7K Q4 '11: -4.8K Q1 '12: -12.1K Q2 '12: -3.9K Q3 '12: -5.1K Q4 '12: -3.8K Q1 '13: -12.2K Q2 '13: -3.7K Q3 '13: -5.2K Q4 '13: -435 Q1 '14: -27.8K Q2 '14: 232.7K Q3 '14: 1.3K Q4 '14: -4K Q1 '15: -331K Q2 '15: -842K Q3 '15: -3.2M Q4 '15: 518.8K Q1 '16: -1.6M Q2 '16: 1.4M Q3 '16: -2.8M Q4 '16: 293.6K Q1 '17: -837.9K Q2 '17: -863.1K Q3 '17: -98.6K Q4 '17: -941.2K Q1 '18: -459.6K Q2 '18: 180.2K Q3 '18: -1.3M Q4 '18: -1M Q1 '19: -984.1K Q2 '19: -490K Q3 '19: 0 Q4 '19: 826.3K Q1 '20: -893.9K Q2 '20: -351.1K Q3 '20: -393.7K Q4 '20: -2.2M Q1 '21: -3.2M Q2 '21: -2M Q3 '21: -2.2M Q4 '21: -4.1M Q1 '22: -4.5M Q2 '22: -4.6M Q3 '22: -4.6M Q4 '22: -3.5M Q1 '23: -5.1M Q2 '23: -4.5M Q3 '23: -2.7M Q4 '23: -1.8M Q1 '24: -2.6M Q2 '24: -2.9M Q3 '24: -927.1K Q4 '24: -1.3M Q1 '25: -2.4M Q2 '25: -1.9M Q3 '25: -2.1M Q4 '25: -1.8M Q1 '26: -2.3M Q2 '26: -2.4M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q1 '22: -5.1M Q2 '22: -4.6M Q3 '22: -4.6M Q4 '22: -3.5M Q1 '23: -5.1M Q2 '23: -4.5M Q3 '23: -2.7M Q4 '23: -1.8M Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q2 '10: 6.5M Q3 '10: 6.5M Q1 '11: 6.5M Q2 '11: 6.5M Q3 '11: 8.5M Q1 '12: 12.1M Q2 '12: 12.1M Q3 '12: 12.1M Q1 '13: 12.1M Q2 '13: 12.1M Q3 '13: 12.1M Q1 '14: 14.9M Q2 '14: 10M Q3 '14: 15.4M Q1 '15: 10M Q2 '15: 17.3M Q3 '15: 10M Q1 '16: 11.9M Q2 '16: 12.8M Q3 '16: 13.7M Q1 '17: 14.1M Q2 '17: 14.6M Q3 '17: 14.7M Q1 '18: 18.7M Q2 '18: 18.8M Q3 '18: 24.2M Q1 '19: 1.8M Q2 '19: 2M Q3 '19: 2.1M Q1 '20: 3.2M Q2 '20: 3.5M Q3 '20: 5.3M Q1 '21: 16.2M Q2 '21: 426.9K Q3 '21: 459.3K Q1 '22: 847.1K Q2 '22: 1.1M Q3 '22: 1.8M Q1 '23: 2.1M Q2 '23: 2.1M Q3 '23: 2.2M Q1 '24: 266.8K Q2 '24: 505.9K Q3 '24: 48.4K Q1 '25: 149.8K Q2 '25: 216.3K Q3 '25: 313.2K Q1 '26: 1.5M Q2 '26: 4M Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-180.00 -120.00 -60.00 0.00 60.00 120.00 180.00 Q4 '10: -0.01 Q1 '11: 0.00 Q2 '11: 0.00 Q3 '11: 0.00 Q4 '11: 0.00 Q1 '12: 0.00 Q2 '12: 0.00 Q3 '12: 0.00 Q4 '12: 0.00 Q1 '13: 0.00 Q2 '13: 0.00 Q3 '13: 0.00 Q4 '13: 0.00 Q1 '14: 0.00 Q2 '14: 0.04 Q3 '14: 0.04 Q4 '14: 0.04 Q1 '15: 0.15 Q2 '15: 0.12 Q3 '15: 0.10 Q4 '16: -0.21 Q1 '17: -0.21 Q2 '17: -0.38 Q3 '17: -0.56 Q4 '17: -0.75 Q1 '18: -0.77 Q2 '18: -0.58 Q3 '18: -0.11 Q4 '18: -20.51 Q1 '19: -21.49 Q2 '19: -22.09 Q3 '19: -22.28 Q4 '19: -2.92 Q1 '20: -2.43 Q2 '20: -2.24 Q3 '20: -2.41 Q4 '20: -2.04 Q1 '21: -1.64 Q3 '22: -11.26 Q4 '22: -14.42 Q1 '23: -11.39 Q2 '23: -11.70 Q3 '23: -11.54 Q4 '23: -121.32 Q1 '24: -128.22 Q2 '24: -128.90 Q3 '24: -170.70 Q4 '24: -113.84 Q1 '25: -119.21 Q2 '25: -127.14 Q3 '25: -94.85 Q4 '25: -37.54 Q1 '26: -24.04 Q2 '26: -13.15 Q4 '11 Q3 '13 Q2 '15 Q1 '18 Q4 '19 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.